Viewing Study NCT03583476



Ignite Creation Date: 2024-05-06 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 12:49 PM
Study NCT ID: NCT03583476
Status: UNKNOWN
Last Update Posted: 2018-07-11
First Post: 2018-06-22

Brief Title: The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection
Sponsor: National Taiwan University Hospital
Organization: National Taiwan University Hospital

Study Overview

Official Title: The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection
Status: UNKNOWN
Status Verified Date: 2018-06
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Clarithromycin CLAamoxicillin AMOmetronidazole METlevofloxacin LEV and tetracycline TET are commonly used antibiotics for Helicobacter pylori Hp therapy However the efficacy of treatment for Helicobacter pylori infection has decreased due to increasing resistance to CLA MET and LEV Studies had reported that beside antibiotics resistance other factors such as age sex underlying disease etc may also affect the treatment efficacy In some cases when the MIC values were beyond the breakpoint H pylori strains with lower MIC value had better eradication than the ones with higher MIC value However few study investigated the relationship between MIC values and treatment outcome

The investigators aimed to analyze the impact of influencing factors especially minimal inhibitory concentration MIC value on the efficacy of different treatment regimens
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None